Biohacking Statistics and Trends (2026)

Last Updated: June 2026

Biohacking is the application of technology, dietary strategy, environmental manipulation, and behavioral science to systematically optimize human biological performance. The term covers a wide and sometimes contradictory range of practices — from rigorously evidence-based interventions with clinical trial data behind them, to experimental self-quantification with uncertain risk profiles, to fringe procedures that have no credible scientific foundation. What unifies the field is its orientation: treating the body and brain not as fixed systems to be maintained but as dynamic systems to be actively improved.

The brain is biohacking’s primary target. Cognitive performance, mental clarity, emotional resilience, memory, focus, and long-term neurological health are the outcomes most consistently sought by the biohacking community — and the domains in which the most commercially significant products and services have been built. Understanding biohacking requires separating the commercially motivated from the scientifically grounded, and being precise about what the evidence actually shows for each technique category.

The statistics in this article are drawn from Grand View Research, the Global Wellness Institute, Applied Psychophysiology and Biofeedback, Cell Metabolism, the Journal of Neurological Sciences, Nature, and additional peer-reviewed sources. For the broader context of how biohacking relates to overall brain health, see our flagship article Brain Health Statistics: 50+ Key Facts (2026).

Key Biohacking Statistics at a Glance

• The global biohacking market was valued at approximately $19.8 billion in 2023 and is projected to grow at a compound annual rate of over 19% through 2030. (Grand View Research)
• Neurofeedback users report up to 25% improvements in sustained attention and focus scores following training programs. (Applied Psychophysiology and Biofeedback)
• Intermittent fasting has been shown to increase BDNF levels and activate autophagy, a cellular repair process critical to long-term brain health. (Cell Metabolism)
• The global wearable technology market exceeded $95 billion in 2023, with cognitive performance monitoring among the fastest-growing application segments. (Statista)
• Cold water immersion reduces cortisol levels by approximately 30% in the hours following exposure. (European Journal of Applied Physiology)
• Transcranial direct current stimulation (tDCS) has shown measurable improvements in working memory and learning speed in multiple controlled trials. (Brain Stimulation)
• Sleep optimization is the single most commonly reported biohacking practice among self-identified biohackers globally, cited by over 60% of survey respondents. (Bulletproof / Oura consumer survey)

The Biohacking Market: Size, Growth, and Demographics

The commercial biohacking industry has grown from a niche subculture centered on Silicon Valley self-experimenters into a mainstream wellness market with significant consumer reach. Understanding who is buying, what they are buying, and why provides essential context for evaluating the industry’s claims.

Market Valuation and Growth

Market sizing for biohacking varies substantially depending on how broadly the category is defined — with different analyses including or excluding supplements, wearables, functional foods, genetic testing, and medical devices.

• The global biohacking market was valued at approximately $19.8 billion in 2023 and is projected to reach approximately $83 billion by 2030 at a CAGR of over 19%. (Grand View Research)
  This growth rate positions biohacking as one of the fastest-expanding sectors in the broader health and wellness industry — roughly triple the growth rate of the traditional healthcare market over the same period.
• North America accounts for the largest share of the global biohacking market, representing approximately 38% of total revenue in 2023. (Grand View Research)
  The U.S. leads North American market share, driven by high consumer health awareness, strong venture capital investment in health technology, and a regulatory environment that permits a wide range of supplements and devices without pre-market approval.
• The brain performance and cognitive enhancement segment represents the largest single application category within the biohacking market, valued at approximately $6.5 billion in 2023. (Allied Market Research)
  Cognitive biohacking commands a premium price point across product categories — from EEG headsets and neurofeedback devices to nootropic stacks and personalized supplementation protocols — reflecting consumers’ willingness to invest in mental performance optimization.
• Venture capital investment in biohacking and human performance optimization companies exceeded $4 billion globally in 2022, with longevity and cognitive enhancement companies receiving the largest individual funding rounds. (CB Insights)
  Investor interest reflects both the commercial potential of the category and the convergence of multiple enabling technologies — genomics, wearable sensors, AI-powered personalization, and advanced supplement formulation — that have matured simultaneously.

Who Biohacks?

The demographic profile of biohacking consumers has shifted substantially from the early adopter phase, expanding from a narrow technical audience to a much broader and more diverse consumer base.

• Millennials represent the largest demographic of biohacking consumers, driven primarily by performance optimization goals rather than longevity or anti-aging motivation. (Grand View Research)
  Millennial biohackers disproportionately focus on productivity, cognitive clarity, and emotional resilience — outcomes aligned with career and competitive pressures rather than the health preservation concerns that motivate older demographics.
• Women now represent approximately 45% of biohacking consumers, up from an estimated 20 to 25% in the early 2010s when the field was heavily male-dominated. (Global Wellness Institute)
  The gender diversification of biohacking has been driven by the growth of female-focused health technology companies, the mainstreaming of wearable health tracking, and the expansion of biohacking discourse beyond bodybuilding and technology communities into broader wellness culture.
• High-performance professionals — including executives, physicians, attorneys, and competitive athletes — represent a disproportionately high share of biohacking spending relative to their share of the general population. (Oura / WHOOP consumer data)
  The concentration of biohacking adoption in high-demand professional environments reflects both the financial ability to invest in premium products and the practical motivation of individuals for whom marginal performance improvements carry high professional value.
• The esports and competitive gaming community has emerged as a significant and rapidly growing biohacking consumer segment, with an estimated 15 to 20% of active gamers using cognitive supplements or wearable performance trackers. (Newzoo / industry surveys)
  Gaming-oriented biohacking emphasizes reaction time, sustained focus, decision speed, and reduced decision fatigue — cognitive outcomes with distinct optimization profiles from those sought by traditional fitness biohackers.

Neurofeedback and Brainwave Training

Neurofeedback is a form of biofeedback that uses real-time electroencephalography (EEG) data to allow individuals to consciously modulate their own brainwave patterns. It is among the best-evidenced neurological biohacking techniques and has established clinical applications alongside its growing consumer market.

• Neurofeedback users report up to 25% improvements in sustained attention and focus scores following structured training programs. (Applied Psychophysiology and Biofeedback)
  These self-reported gains are supported by objective cognitive test performance improvements in multiple controlled trials, though effect sizes vary considerably across studies and populations.
• Neurofeedback has the strongest evidence base for ADHD treatment of any biofeedback modality, with multiple meta-analyses confirming significant improvements in inattention and hyperactivity that show durability beyond the training period. (European Child and Adolescent Psychiatry)
  The durability of neurofeedback effects — in contrast to the immediate reversibility of medication effects — is one of its most clinically meaningful features and a primary motivation for its use as an ADHD adjunct.
• Professional athletes, including Olympic competitors, have used neurofeedback for performance enhancement since the 1980s, with some national sports programs incorporating it as a standard training element. (Journal of Neurotherapy)
  The use of neurofeedback for peak performance — rather than clinical treatment — has a longer history than most consumer biohacking techniques, providing a substantial longitudinal dataset of performance outcomes in elite populations.
• Consumer EEG headsets for neurofeedback — sold by companies including Muse, NeuroSky, and Emotiv — have made brainwave training accessible outside clinical settings, with the consumer EEG market projected to reach $1.8 billion by 2028. (MarketsandMarkets)
  Consumer-grade EEG devices have significantly lower electrode counts and signal fidelity than clinical systems, raising questions about the comparability of outcomes between clinical and consumer neurofeedback training.
• Alpha wave neurofeedback training — specifically targeting the 8 to 12 Hz frequency associated with relaxed alertness — has shown improvements in creativity performance scores in multiple small controlled trials. (Applied Psychophysiology and Biofeedback)
  This finding connects neurofeedback to the broader neuroscience of creativity, where alpha wave activity in the resting brain is associated with the default mode network engagement that underlies generative thinking.

Dietary Biohacking: Fasting, Ketosis, and Metabolic Optimization

Dietary manipulation is among the most widely practiced and most evidence-backed categories of biohacking with direct neurological relevance. Specific dietary patterns and feeding schedules produce measurable effects on brain metabolism, neurochemistry, and cellular maintenance processes.

Intermittent Fasting and the Brain

Intermittent fasting — restricting caloric intake to specific time windows rather than reducing overall calories — has become one of the most widely adopted biohacking dietary protocols, with a growing neurological evidence base.

• Intermittent fasting increases BDNF levels in the brain, promoting neuronal growth and maintenance through the same pathways stimulated by aerobic exercise. (Cell Metabolism)
  The convergence of intermittent fasting and exercise on BDNF elevation suggests that combining the two practices may produce additive neurological benefits — a hypothesis that is generating increasing research interest.
• Intermittent fasting activates autophagy — the cellular self-cleaning process through which damaged proteins and organelles are broken down and recycled — in brain cells as well as peripheral tissues. (Cell Metabolism)
  Autophagy in neurons is critical to the clearance of protein aggregates associated with neurodegenerative disease, including the amyloid-beta and tau proteins that accumulate in Alzheimer’s disease. Its activation through dietary fasting represents a potentially meaningful preventive mechanism.
• A 16:8 intermittent fasting protocol — eating within an eight-hour window and fasting for sixteen hours — improves insulin sensitivity and reduces neuroinflammation markers in multiple human clinical studies. (Obesity Reviews)
  Insulin resistance in the brain is increasingly implicated in Alzheimer’s disease pathology — making dietary practices that improve insulin sensitivity potentially protective against neurodegeneration through this pathway.
• Extended fasting periods of 24 to 72 hours significantly upregulate ketone production, providing the brain with an alternative fuel source to glucose that many researchers believe is neuroprotective. (New England Journal of Medicine)
  The brain can run efficiently on ketone bodies when glucose is limited, and ketone metabolism produces fewer reactive oxygen species than glucose metabolism — a potential mechanism for the reduced oxidative stress associated with fasting.
• Caloric restriction of 15 to 25% — a more extreme dietary biohacking protocol — has extended lifespan and healthspan in multiple animal models and produced improved cognitive performance and reduced inflammatory markers in the CALERIE human trial. (NEJM Evidence)
  The human evidence for caloric restriction’s cognitive benefits remains limited in duration and scale — long-term trials are methodologically difficult to conduct — but the mechanistic evidence from animal and short-term human studies is consistent.

Ketogenic Diet and Brain Performance

The ketogenic diet — a very low carbohydrate, high fat dietary pattern that shifts primary brain fuel from glucose to ketone bodies — has moved from a clinical epilepsy treatment into the broader biohacking consciousness, with a growing neurological evidence base.

• The ketogenic diet has been used clinically for epilepsy treatment since the 1920s, with approximately 50% of treatment-resistant pediatric epilepsy patients achieving significant seizure reduction. (Lancet Neurology)
  The ketogenic diet’s established clinical history provides a level of safety and efficacy documentation that most biohacking dietary protocols lack — though clinical epilepsy applications differ substantially from performance optimization contexts.
• Several small clinical trials have shown improved cognitive performance in adults with mild cognitive impairment following ketogenic dietary intervention, with effects correlated with blood ketone levels. (Frontiers in Aging Neuroscience)
  The hypothesis that the Alzheimer’s-affected brain has impaired glucose metabolism but preserved ketone metabolism — making dietary ketosis a potential metabolic workaround — is one of the most actively investigated ideas in Alzheimer’s nutritional research.
• Self-reported cognitive clarity and mental acuity are among the most commonly cited benefits by individuals following ketogenic diets, though controlled trial evidence for cognitive enhancement in healthy adults is limited. (Journal of Nutrition and Metabolism)
  The gap between widespread anecdotal reporting of cognitive benefits and limited controlled trial evidence is characteristic of many biohacking claims — a pattern that warrants both open inquiry and methodological rigor.

Wearable Technology and Cognitive Performance Monitoring

The proliferation of wearable sensors capable of continuously measuring physiological variables has created an entirely new category of biohacking — one in which cognitive optimization is pursued through data-driven personalization rather than fixed protocol adoption. The market scale of this technology reflects both consumer demand and the practical value of real-time biological feedback.

• The global wearable technology market exceeded $95 billion in 2023, with health and performance monitoring wearables representing the dominant and fastest-growing application category. (Statista)
  Smartwatches, fitness trackers, continuous glucose monitors, sleep trackers, and EEG headsets have collectively democratized physiological monitoring previously available only in clinical or research settings.
• Continuous glucose monitors (CGMs), originally developed for diabetic patients, are now used by an estimated 30 to 40% of biohacking consumers who do not have diabetes, to optimize meal timing, food choices, and cognitive performance based on real-time blood glucose data. (Global Wellness Institute)
  Glucose stability — avoiding sharp spikes and crashes — is associated with more stable cognitive performance and mood throughout the day, providing a neurologically relevant rationale for glucose monitoring beyond glycemic disease management.
• Sleep tracking wearables have been shown to meaningfully increase user awareness of sleep habits and produce behavioral changes that improve sleep quality in a significant proportion of users — though their accuracy in measuring sleep stages is substantially lower than clinical polysomnography. (Journal of Clinical Sleep Medicine)
  The behavioral change driven by sleep data visibility may be the most practically significant benefit of sleep tracking technology — awareness of chronic sleep deficits motivates changes that the deficit itself, often subjectively normalized, does not.
• Heart rate variability (HRV) monitoring — measuring the variation in time between heartbeats as a proxy for autonomic nervous system balance and stress resilience — is used by an estimated 25 million wearable device users globally. (Oura / WHOOP user data)
  HRV is one of the most validated physiological markers of readiness and recovery in the sports science literature, and its application to cognitive performance readiness — predicting optimal days for demanding cognitive work — is an active area of biohacking research.
• Athletes who train using HRV-guided protocols show superior performance outcomes compared to those using fixed training schedules, with reductions in overtraining and injury and better long-term performance progression. (International Journal of Sports Physiology and Performance)
  The application of HRV-guided scheduling to cognitive work — resting cognitive systems when HRV indicates incomplete recovery — mirrors the athletic application and represents one of the most data-grounded approaches in cognitive biohacking.

Non-Invasive Brain Stimulation

Electrical and magnetic brain stimulation techniques that influence neural activity from outside the skull represent one of the most technically sophisticated categories of cognitive biohacking. Several of these techniques have moved from academic research settings into consumer products — with a variable and frequently disputed evidence base.

Transcranial Direct Current Stimulation

Transcranial direct current stimulation (tDCS) delivers weak electrical currents to specific brain regions through electrodes placed on the scalp, with the intent of modulating neural excitability in targeted areas.

• tDCS applied to the left dorsolateral prefrontal cortex has shown measurable improvements in working memory and learning speed in multiple controlled trials involving healthy adults. (Brain Stimulation)
  The dorsolateral prefrontal cortex is the brain region most associated with working memory, executive function, and the cognitive control processes targeted by most cognitive biohacking interventions.
• A meta-analysis of 94 tDCS studies found significant positive effects on attention, working memory, and language performance, with effect sizes in the small-to-moderate range. (Neuroscience and Biobehavioral Reviews)
  Small-to-moderate effect sizes are consistent with what would be expected from a technique that modulates neural excitability without fundamentally altering brain architecture — meaningful for some applications, insufficient for others.
• Consumer tDCS devices are widely available for purchase online at prices ranging from $200 to $1,500, without prescription or clinical oversight. (FDA consumer alert)
  The FDA has issued consumer alerts regarding the use of non-prescription tDCS devices, noting that safety and efficacy for cognitive enhancement have not been established for consumer versions and that risks include skin burns, headache, and the possibility of worsening cognitive performance in some applications.
• The reproducibility of tDCS cognitive effects across studies has been challenged, with several large pre-registered replication attempts failing to confirm earlier positive findings in healthy adults. (Brain Stimulation)
  This replication uncertainty is one of the most significant unresolved issues in the tDCS literature and underscores the gap between early enthusiasm and established efficacy — a pattern common across many biohacking technologies.

Transcranial Magnetic Stimulation and Photobiomodulation

Beyond tDCS, several other non-invasive brain stimulation modalities have attracted significant research and commercial interest.

• Repetitive transcranial magnetic stimulation (rTMS) is FDA-approved for treatment-resistant depression and OCD and has produced significant symptom reduction in clinical trials, with approval expanding to additional indications. (FDA)
  rTMS’s clinical approval distinguishes it from most biohacking brain stimulation techniques, providing a level of regulatory and evidence validation that consumer tDCS devices lack.
• Photobiomodulation — the application of near-infrared or red light to the scalp — has shown preliminary evidence of improving cognitive performance and reducing symptoms of mild cognitive impairment in small clinical trials. (Journal of Neurological Sciences)
  The proposed mechanism involves cytochrome c oxidase activation in mitochondria — increasing cellular energy production in neural tissue — a plausible biological pathway that justifies continued investigation despite limited current evidence.
• Gamma frequency light and sound stimulation at 40 Hz has shown promising results in reducing amyloid burden and improving cognitive performance in early Alzheimer’s mouse models, with Phase 2 human trials in progress. (Cell, MIT)
  This research, originating from Li-Huei Tsai’s laboratory at MIT, represents one of the most intriguing intersections of sensory biohacking and neurodegenerative disease — though the translation from mouse models to human clinical benefit remains to be established.

Temperature, Cold Exposure, and the Brain

Temperature manipulation — primarily cold water immersion, cold showers, and heat exposure through sauna — has become one of the most widely discussed biohacking categories, with a neurological evidence base that is more robust than many other popular techniques.

• Cold water immersion reduces cortisol levels by approximately 30% in the hours following exposure, producing a parasympathetic nervous system response that reduces perceived stress and improves mood. (European Journal of Applied Physiology)
  The cortisol reduction following cold exposure is one of the more consistently measured physiological effects in this category, providing a neurochemical mechanism for the mood and stress-reduction benefits widely reported by cold exposure practitioners.
• Cold exposure increases norepinephrine levels by 200 to 300%, a neurochemical effect that drives enhanced alertness, focus, and mood elevation. (European Journal of Applied Physiology)
  Norepinephrine’s role in prefrontal cortex function — supporting working memory, attention, and cognitive control — provides a specific neurological mechanism for the cognitive clarity many cold exposure practitioners report.
• Regular sauna use is associated with a significantly reduced risk of dementia and Alzheimer’s disease, with Finnish longitudinal data showing a 65% risk reduction in men who sauna four to seven times per week compared to those who do it once weekly. (Age and Ageing)
  The dementia-protective mechanism of regular sauna use likely involves cardiovascular benefit, heat shock protein production, and the stress-inoculation effects of deliberate physiological challenge — multiple overlapping pathways rather than a single mechanism.
• Heat shock proteins (HSPs) produced during sauna and heat exposure act as molecular chaperones that help properly fold proteins and clear misfolded aggregates — including those associated with neurodegenerative disease. (Frontiers in Physiology)
  The role of heat shock proteins in protein quality control provides a plausible molecular mechanism for sauna’s apparent neuroprotective effects, connecting the biological response to deliberate heat stress with the pathology of Alzheimer’s and Parkinson’s disease.
• Cold-hot contrast therapy — alternating cold and heat exposure — produces greater increases in growth hormone and BDNF than either modality alone in several small studies. (International Journal of Sports Medicine)
  While the research on contrast therapy is limited and preliminary, the additive effects on growth hormone and BDNF — both of which support neuronal maintenance and repair — warrant continued investigation.

Sleep Optimization as Biohacking

Among all biohacking categories, sleep optimization has the most robust evidence base, the most direct neurological benefit, and the highest reported adoption among self-identified biohackers. It is also the domain where the gap between what the science recommends and what most people do is widest.

• Sleep optimization is the single most commonly reported biohacking practice globally, cited by over 60% of self-identified biohackers in consumer surveys. (Bulletproof / Oura consumer survey)
  The primacy of sleep in biohacking communities reflects a genuine convergence of scientific evidence and practical experience — optimizing sleep produces among the largest and most reliable cognitive improvements available through any lifestyle intervention.
• Wearable sleep trackers have been shown to increase average sleep duration by approximately 15 to 30 minutes per night in users who actively engage with their data. (npj Digital Medicine)
  Even a modest increase in nightly sleep duration of 20 minutes produces measurable improvements in cognitive performance the following day — making sleep tracking an accessible high-return biohacking intervention.
• Sleep environment optimization — specifically reducing bedroom temperature to 65 to 68 degrees Fahrenheit — is associated with significantly faster sleep onset and greater slow-wave sleep duration. (Journal of Physiological Anthropology)
  Core body temperature must drop approximately one to two degrees to initiate sleep — a physiological requirement that makes bedroom temperature one of the most mechanistically grounded sleep optimization recommendations available.
• Magnesium supplementation — particularly in the glycinate and threonate forms — has shown improvements in sleep quality and sleep onset latency in adults with low dietary magnesium intake. (Journal of Research in Medical Sciences)
  Magnesium’s role in GABA receptor function and melatonin synthesis provides a plausible biological mechanism for its sleep-facilitating effects — and its deficiency is sufficiently common in modern diets that supplementation may address a genuine gap for a large proportion of adults.

For comprehensive data on sleep’s neurological effects and the consequences of deprivation, see our article on Sleep and Brain Health Statistics. For data on how dietary strategies specifically affect brain function and cognitive aging, see Nutrition and Brain Health Statistics.

The Evidence Hierarchy in Biohacking

Biohacking’s commercial exuberance frequently outpaces its scientific evidence base. Applying a clear framework for evaluating claims is essential for anyone seeking to distinguish the genuinely beneficial from the merely trendy or commercially motivated.

• Techniques with the strongest evidence bases — including sleep optimization, regular aerobic exercise, intermittent fasting, and dietary pattern improvement — are also among the least commercially glamorous and least profitable to market. (Multiple systematic reviews)
  The inverse relationship between commercial marketing intensity and scientific evidence quality is a recurring pattern in biohacking, and a useful heuristic for evaluating novel claims.
• Techniques with moderate and growing evidence bases — including neurofeedback for ADHD, sauna for cardiovascular and possibly dementia risk, cold exposure for mood and norepinephrine, and photobiomodulation for mild cognitive impairment — warrant continued investigation and cautious adoption. (Respective primary literature)
  These techniques share a common feature: plausible biological mechanisms, preliminary positive human data, and ongoing or planned larger trials that will more definitively establish efficacy and safety.
• Techniques with weak, absent, or contradicted evidence bases — including many consumer neurostimulation devices, proprietary supplement “stacks” with novel ingredients, and implantable biohacking devices — carry uncertain risk-benefit profiles that reasonable consumers should approach with significant skepticism. (FDA, systematic reviews)
  The absence of evidence is not evidence of absence — but in a domain with significant financial incentives and limited regulatory oversight, the burden of proof should rest with efficacy claims rather than with skeptics.
• N-of-1 experimentation — systematic self-experimentation with controlled variables and tracked outcomes — is the most practically accessible form of rigorous biohacking and can generate meaningful personal data even when population-level evidence is limited. (Journal of the American Medical Informatics Association)
  The systematic tracking of personal response to interventions — with defined baseline periods, consistent measurement, and controlled variable changes — produces more meaningful data than anecdotal experience, even if it cannot establish population-level effects.

For data on the nootropics category specifically — the supplement component of cognitive biohacking — see our article on Nootropics Industry Statistics and Market Data. For data on how AI tools are being integrated into biohacking and cognitive optimization, see AI and Cognitive Impact Statistics.

Key Takeaways

• The global biohacking market is projected to reach approximately $83 billion by 2030, driven by cognitive performance applications — but the commercial scale of the industry has substantially outpaced the scientific evidence base for most novel techniques, making evidence literacy a critical consumer skill. (Grand View Research)
• Sleep optimization is the most widely adopted biohacking practice and also the most evidence-backed: even a modest 20-minute increase in nightly sleep duration from wearable-guided habit change produces measurable next-day cognitive improvement, with no financial cost beyond the tracking device. (npj Digital Medicine, Bulletproof / Oura surveys)
• Neurofeedback has the most robust evidence base of any active cognitive biohacking technology, with particularly strong support for ADHD treatment, demonstrated durability of effects beyond the training period, and a growing clinical validation record that distinguishes it from most consumer brain stimulation devices. (European Child and Adolescent Psychiatry)
• Intermittent fasting increases BDNF and activates autophagy in brain cells through mechanisms that parallel the neurological effects of aerobic exercise — making it one of the dietary biohacking approaches with the most direct and plausible neurological benefit. (Cell Metabolism)
• Regular sauna use is associated with a 65% reduction in dementia risk in men who use it four to seven times per week — the strongest single dementia risk-reduction statistic associated with any temperature-based biohacking practice, and one grounded in a longitudinal dataset spanning decades. (Age and Ageing)

Explore the Full Brain Health Statistics Series

• Brain Health Statistics: 50+ Key Facts (2026)
• Dementia and Alzheimer’s Statistics
• Sleep and Brain Health Statistics
• Nootropics Industry Statistics and Market Data
• Mental Health and Cognitive Function Statistics
• Brain Health Statistics by Age
• Exercise and Brain Health Statistics
• Screen Time and Brain Health Statistics
• Nutrition and Brain Health Statistics
• Stress and the Brain: Key Statistics
• Student Brain Health and Academic Performance Statistics
• Creativity and the Brain: Key Statistics
• Biohacking Statistics and Trends
• AI and Cognitive Impact Statistics
• Brain Injury and Concussion Statistics